Stocks
Applied Therapeutics (APLT) EV/EBITDA US GAAP (year values) |
|||||||||
| FY2020 | FY2021 | FY2022 | FY2023 | FY2024 | LTM ? | CAGR 5 years ? | |||
| EV/EBITDA | ? | -4.12 | -1.42 | 0.35 | 0.76 | -0.41 | -0.78 | ||
| Changes by years, y/y, % | -40% | -65% | -124% | +118% | -153% | -43.2% | |||
Applied Therapeutics. EV/EBITDA
Applied Therapeutics. EV/EBITDA, changes, %
Applied Therapeutics (APLT) EV/EBITDA US GAAP (quarter values) |
||||||||
| FY2024Q3 | FY2024Q4 | FY2025Q1 | FY2025Q2 | FY2025Q3 | LTM ? | |||
| EV/EBITDA | ? | -12.3 | -1.55 | -0.82 | -0.60 | -4.38 | -0.78 | |
| Changes by years, y/y, % | -2 215% | -303% | -142% | -138% | -64% | |||
| Changes by quarters, q/q, % | -883% | -87% | -47% | -26% | +626% | |||
